F. Delorme
Impact in
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
- Periodontics top 5%
- Oral microbiology and periodontitis research
Papers in
- Co-authors
- Louis Desjardins (2 shared papers)Jacques R. Leclerc (2 shared papers)William Geerts (2 shared papers)F Laroche (1 shared paper)F Jobin (1 shared paper)Elizabeth A. Eisenhauer (1 shared paper)A. Muldal (1 shared paper)B. Norris (1 shared paper)
In The Last Decade
F. Delorme
16 papers receiving 470 citations
Peers
Comparison fields: 5 of 58
- Internal Medicine 192
- Periodontics 63
- Cardiology and Cardiovascular Medicine 122
- Oncology 132
- Pharmacy 15
Countries citing papers authored by F. Delorme
This map shows the geographic impact of F. Delorme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Delorme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Delorme more than expected).
Fields of papers citing papers by F. Delorme
This network shows the impact of papers produced by F. Delorme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Delorme. The network helps show where F. Delorme may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Delorme, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 186 | |
| 2 | 1996 | 137 | |
| 3 | 1989 | 53 | |
| 4 | Prevention of Venous Thromboembolism after Knee Arthroplasty | 1996 | 29 |
| 5 | Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer. | 1997 | 24 |
| 6 | 1988 | 16 | |
| 7 | 1992 | 15 | |
| 8 | 1998 | 15 | |
| 9 | 1980 | 13 | |
| 10 | 1989 | 7 | |
| 11 | Daunorubicin-albumin copolymer targeting to leukemic cells in vitro and in vivo. | 1984 | 6 |
| 12 | 1996 | 5 | |
| 13 | 1997 | 5 | |
| 14 | 1997 | 5 | |
| 15 | Chemotherapy with daunorubicin-anti-CEA conjugates in human colon adenocarcinoma grafted in nude mice. | 1984 | 3 |
| 16 | [Dissecting aneurysm and rupture of the aorto secondary to giant-cell aortitis. Case report and review of the literature]. | 1970 | 2 |
| 17 | 1985 | 1 |
About F. Delorme
F. Delorme is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Internal Medicine, having authored 17 papers that have together received 522 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Oral microbiology and periodontitis research (3 papers), Breast Cancer Treatment Studies (2 papers), Neutropenia and Cancer Infections (2 papers), Glycosylation and Glycoproteins Research (1 paper), Streptococcal Infections and Treatments (1 paper) and Heparin-Induced Thrombocytopenia and Thrombosis (1 paper). The work is most often cited by research in Internal Medicine (192 citations), Periodontics (63 citations), Cardiology and Cardiovascular Medicine (122 citations), Oncology (132 citations) and Pharmacy (15 citations). F. Delorme has collaborated with scholars based in Canada and India. Frequent co-authors include Louis Desjardins, Jacques R. Leclerc, William Geerts, F Laroche, F Jobin, Elizabeth A. Eisenhauer, A. Muldal, B. Norris, F Letendre and Theodore A. Vandenberg. Their work appears in journals such as Thrombosis and Haemostasis, British Journal of Haematology, Journal of Periodontology, Antimicrobial Agents and Chemotherapy and Journal of the American Society of Echocardiography.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.